One of the biggest and most significant events in the biotechnology
industry was held in Boston (USA), June 18-21. The key players of the
world's biotechnology community, delegations from 69 countries took part
in the conference, discussed the opportunities of biotechnology
development, got to know interesting innovative projects.
The event’s program was conditionally divided into three parts:
scientific sessions and panels, exhibitions and business forum aimed at
establishing of important business contacts between companies. This year
the conference brought together more than 16,000 professionals from
over 1,600 companies.
The Russian delegation was headed by the Ministry of Industry and
Trade of the Russian Federation. The Russian pavilion was represented by
the leading pharmaceutical companies of Russia that develop innovative
projects in the field of biotechnology within the framework of the
“Strategy Pharma 2020”. GEROPHARM was one of the companies at that
During the busy business program within BIO International Convention
2012 representatives of GEROPHARM were open for cooperation and held
more than 50 important business meetings.
Today, one of the most important GEROPHARM’ strategic goals is
expanding the product portfolio. Particular attention is paid to the
development of innovative drugs. Developments works are carried out on
the basis of a new, modern R&D centre of the company in the Neudorf
special economic zone. Some projects are implemented in cooperation with
scientific companies of USA, Japan, Australia, Italy and other
BIO International Convention Conference has been held for almost 20 years, and the first conference was organized in 1993. BIO International Convention 2013 will take place in Chicago, USA.